262 related articles for article (PubMed ID: 11134513)
1. Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin.
Furumai R; Komatsu Y; Nishino N; Khochbin S; Yoshida M; Horinouchi S
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):87-92. PubMed ID: 11134513
[TBL] [Abstract][Full Text] [Related]
2. Macrocyclic Octapeptide Binding and Inferences on Protein Substrate Binding to Histone Deacetylase 6.
Watson PR; Gupta S; Hosseinzadeh P; Brown BP; Baker D; Christianson DW
ACS Chem Biol; 2023 Apr; 18(4):959-968. PubMed ID: 37027789
[TBL] [Abstract][Full Text] [Related]
3. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation.
Matsuyama A; Shimazu T; Sumida Y; Saito A; Yoshimatsu Y; Seigneurin-Berny D; Osada H; Komatsu Y; Nishino N; Khochbin S; Horinouchi S; Yoshida M
EMBO J; 2002 Dec; 21(24):6820-31. PubMed ID: 12486003
[TBL] [Abstract][Full Text] [Related]
4. Histone acetyltransferases regulate HIV-1 enhancer activity in vitro.
Sheridan PL; Mayall TP; Verdin E; Jones KA
Genes Dev; 1997 Dec; 11(24):3327-40. PubMed ID: 9407026
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of HDAC6 inhibitors targeting L1 loop and serine 531 residue.
Jha S; Kim JH; Kim M; Nguyen AH; Ali KH; Gupta SK; Park SY; Ha E; Seo YH
Eur J Med Chem; 2024 Feb; 265():116057. PubMed ID: 38142511
[TBL] [Abstract][Full Text] [Related]
6. Probing the bioactive conformation of an archetypal natural product HDAC inhibitor with conformationally homogeneous triazole-modified cyclic tetrapeptides.
Horne WS; Olsen CA; Beierle JM; Montero A; Ghadiri MR
Angew Chem Int Ed Engl; 2009; 48(26):4718-24. PubMed ID: 19267380
[TBL] [Abstract][Full Text] [Related]
7. The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors.
Sodji Q; Patil V; Jain S; Kornacki JR; Mrksich M; Tekwani BL; Oyelere AK
Bioorg Med Chem Lett; 2014 Oct; 24(20):4826-30. PubMed ID: 25240614
[TBL] [Abstract][Full Text] [Related]
8. Re-exploration of tetrahydro-β-carboline scaffold: Discovery of selective histone deacetylase 6 inhibitors with neurite outgrowth-promoting and neuroprotective activities.
Wen W; Hu J; Wang C; Yang R; Zhang Y; Huang B; Qiao T; Wang J; Chen X
Bioorg Med Chem Lett; 2024 Apr; 102():129670. PubMed ID: 38387692
[TBL] [Abstract][Full Text] [Related]
9. Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase
König B; Watson PR; Reßing N; Cragin AD; Schäker-Hübner L; Christianson DW; Hansen FK
J Med Chem; 2023 Oct; 66(19):13821-13837. PubMed ID: 37782298
[TBL] [Abstract][Full Text] [Related]
10. Zinc chelation with hydroxamate in histone deacetylases modulated by water access to the linker binding channel.
Wu R; Lu Z; Cao Z; Zhang Y
J Am Chem Soc; 2011 Apr; 133(16):6110-3. PubMed ID: 21456530
[TBL] [Abstract][Full Text] [Related]
11. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors.
Tavares MT; Krüger A; Yan SLR; Waitman KB; Gomes VM; de Oliveira DS; Paz F; Hilscher S; Schutkowski M; Sippl W; Ruiz C; Toledo MFZJ; Hassimotto NMA; Machado-Neto JA; Poso A; Cameron MD; Bannister TD; Palmisano G; Wrenger C; Kronenberger T; Parise-Filho R
Sci Rep; 2023 Nov; 13(1):21006. PubMed ID: 38030668
[TBL] [Abstract][Full Text] [Related]
12. A hydroxamic-acid-containing nucleoside inhibits DNA repair nuclease SNM1A.
Doherty W; Dürr EM; Baddock HT; Lee SY; McHugh PJ; Brown T; Senge MO; Scanlan EM; McGouran JF
Org Biomol Chem; 2019 Sep; 17(35):8094-8105. PubMed ID: 31380542
[TBL] [Abstract][Full Text] [Related]
13. A potent HDAC inhibitor, 1-alaninechlamydocin, from a Tolypocladium sp. induces G2/M cell cycle arrest and apoptosis in MIA PaCa-2 cells.
Du L; Risinger AL; King JB; Powell DR; Cichewicz RH
J Nat Prod; 2014 Jul; 77(7):1753-7. PubMed ID: 24999749
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies of a macrocyclic peptide inhibitor of histone lysine demethylase 4A.
Passioura T; Bhushan B; Tumber A; Kawamura A; Suga H
Bioorg Med Chem; 2018 Mar; 26(6):1225-1231. PubMed ID: 29402611
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and HDAC inhibitory activity of pyrimidine-based hydroxamic acids.
Jakubkiene V; Valiulis GE; Schweipert M; Zubriene A; Matulis D; Meyer-Almes FJ; Tumkevicius S
Beilstein J Org Chem; 2022; 18():837-844. PubMed ID: 35923158
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Novel Metalloenzyme Inhibitors Based on Property Characterization: Strategy and Application for HDAC1 Inhibitors.
Zhang L; Yang Y; Yang Y; Xiao Z
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474606
[TBL] [Abstract][Full Text] [Related]
17. Psammaplin A analogues with modified disulfide bond targeting histone deacetylases: Synthesis and biological evaluation.
Jiang Y; Tang Y; Li Y; Liu L; Yue K; Li X; Qiu P; Yin R; Jiang T
Eur J Med Chem; 2024 May; 275():116541. PubMed ID: 38851056
[TBL] [Abstract][Full Text] [Related]
18. Crystal Structure of Histone Deacetylase 6 Complexed with (
Watson PR; Stollmaier JG; Christianson DW
bioRxiv; 2023 Aug; ():. PubMed ID: 37609266
[TBL] [Abstract][Full Text] [Related]
19. Structural insight into the macrocyclic inhibitor TPX-0022 of c-Met and c-Src.
Qu L; Lin H; Dai S; Guo M; Chen X; Jiang L; Zhang H; Li M; Liang X; Chen Z; Wei H; Chen Y
Comput Struct Biotechnol J; 2023; 21():5712-5718. PubMed ID: 38074469
[TBL] [Abstract][Full Text] [Related]
20. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.
Vigushin DM; Ali S; Pace PE; Mirsaidi N; Ito K; Adcock I; Coombes RC
Clin Cancer Res; 2001 Apr; 7(4):971-6. PubMed ID: 11309348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
